1. Pradalier A, Willer JC, Dry J. Pain sensitivity in obese individuals.
Ann Med Interne (Paris) 1982;133:528–31.
2. Guieu R, Blin O, Pouget J, Serratrice G. Nociceptive threshold and
physical activity. Can J Neurol Sci 1992;19:69–71.
3. Fordyce W, McMahon R, Rainwater G, et al. Pain
complaint—exercise performance relationship in chronic pain. Pain
1981;10:311–21.
4. Schwarz L, Kindermann W. Changes in beta-endorphin levels in response
to aerobic and anaerobic exercise. Sports Med 1992;13:25–36 [review].
5. Ferrell BA, Josephson KR, Pollan AM, et al. A randomized trial of
walking versus physical methods for chronic pain management. Aging (Milano)
1997;9:99–105.
6. McCain GA. Nonmedicinal treatments in primary fibromyalgia. Rheum
Dis Clin North Am 1989;15:73–90.
7. Kottke TE, Caspersen CJ, Hill CS. Exercise in the management and
rehabilitation of selected chronic diseases. Prev Med 1984;13:47–65
[review].
8. Cowan P, Lovasik DA. American Chronic Pain Association: strategies for
surviving chronic pain. Orthop Nurs 1990;9:47–9 [review].
9. Ehrenpreis S. Analgesic properties of enkephalinase inhibitors: animal
and human studies. Prog Clin Biol Res 1985;192:363–70.
10. Guisti P, Carrara M, Cima L, Borin G. Antinociceptive effect of some
carboxypeptidase A inhibitors in comparison with D-phenylalanine. Eur J Pharmacol
1985;116:287–92.
11. Walsh NE, Ramamurthy S, Schoenfeld LS, Hoffman J. D-phenylalanine was
not found to exhibit opiod receptor mediated analgesia in monkeys. Pain
1986;26:409–10.
12. Ehrenpreis S, Balagot R, Comaty JE, Myles SB. Naloxonr reversible
analgesia in mice produced by D-phenylalanine and hydrocinnamic acid, inhibitors of
carboxypeptidase A. In Bonica JJ, et al., eds. Advances in Pain Research and Therapy, Vol.
3. New York: Raven Press, 1979.
13. Ehrenpreis S. Pharmacology of enkephalinase inhibitors: animal and
human studies. Acupunct Electrother Res. 1985;10:203–8.
14. Balagot RC, Ehrenpreis S, Kubota K, Greenberg J. Analgesia in mice
and humans by D-phenylalanine: relation to inhibition of enkephalin degradation amd enkephalin
levels. In Bonica JJ, et al., eds. Advances in Pain Research and Therapy, Vol. 5. New
York: Raven Press, 1983
15. Mitchell MJ, Daines GE, Thomas BL. Effect of L-tryptophan and
phenylalanine on burning pain threshold. Phys Ther 1987;67:203–5.
16. D’Alessandro R. D-Phenylalanine does not affect nociceptive,
flexion reflex thresholds in normal humans. Anesth Analg 1983;62:857–8.
17. Budd K. Use of D-phenylalanine, an enkephalinase inhibitor, in the
treatment of intractable pain. In Bonica JJ, et al., eds. Advances in Pain Research and
Therapy, Vol. 5. New York: Raven Press, 1983.
18. Donzelle G, Bernard L, Deumier R, et al. Curing trial of complicated
oncologic pain by D-phenylalanine. Anesthesie, Analgesie, Reanimation
1981;38:655–8 [in French].
19. Balagot RC, Ehrenpreis S, Kubota K, Greenberg J. Analgesia in mice
and humans by D-phenylalanine: relation to inhibition of enkephalin degradation and enkephalin
levels. In Bonica JJ, et al., eds. Advances in Pain Research and Therapy, Vol. 5. New
York: Raven Press, 1983.
20. Walsh NE, Ramamurthy S, Schoenfeld LS, Hoffman J. Analgesic
effectiveness of D-phenylalanine in chronic pain patients. Arch Phys Med Rehabil
1986;67:436–9.
21. Sicuteri F. Enkephalinase inhibition relieves pain syndromes of
central dysnociception (migraine and related headache). Cephalalgia
1981;1:229–32.
22. Kitade T, Minamikawa M, Nawata T, et al. An experimantal study on the
enhancing effects of phenylalanine on acupuncture analgesia. Am J Chin Med
1981;9:243–8.
23. Takeshige C, Mera H, Hisamitsu T, et al. Inhibition of the analgesia
inhibitory system by D-phenylalanine and proglumide. Brain Res Bull
1991;26:385–91.
24. Kitade T, Odahara Y, Shinohara S, et al. Studies on the enhanced
effect of acupuncture analgesia and acupuncture anesthesia by D-phenylalanine (first
report)—effect on pain threshold and inhibition by naloxone. Acupunct Electrother
Res 1988;13:87–97.
25. Kitade T, Odahara Y, Shinohara S, et al. Studies on the enhanced
effect of acupuncture analgesia and acupuncture anesthesia bu D-phenylalanine (2nd
report)—schedule of administration and clinical effects in low back pain and tooth
extraction. Acupunct Electrother Res 1990;15:121–35.
26. Leiberman HR, Corkin S, Spring RJ, et al. Mood, performance and pain
sensitivity: changes induced by food constituents. J Psychiatr Res
1982;17:135–45.
27. Shpeen SE, Morse DR, Furst ML. The effect of tryptophan on
post-operative endodontic pain. Oral Surg Oral Med Oral Pathol 1984;58:
446–9.
28. Seltzer S, Dewart D, Pollack RL, Jackson E. The effects of dietary
tryptophan on chronic maxillofacial pain and experimental pain tolerance. J Psychiatr
Res 1982–83;17(2):185–6.
29. Hanck A, Weiser H. Analgesic and anti-inflammatory properties of
vitamins. Int J Vitam Nutr Res Suppl 1985;27:189–206.
30. Hieber H. Treatment of vertebragenous pain and sensitivity disorders
using high doses of hydroxocobalamin. Med Monatsschr 1974;28:545–8 [in
German].
31. Santos AR, Calixto JB. Ruthenium red and capsazepine antinociceptive
effect in formalin and capsaicin models of pain in mice. Neurosci Lett.
1997;235:73–6.
32. Otsuki T, Nakahama H, Niizuma H, Suzuki J. Evaluation of the
analgesic effects of capsaicin using a new rat model for tonic pain. Brain Res
1986;365:235–40.
33. Nolano M, Simone DA, Wendelschafer-Crabb G, et al. Topical capsaicin
in humans: parallel loss of epidermal nerve fibers and pain sensation. Pain
1999;81:135–45.
34. Kingery WS. A critical review of controlled clinical trials for
peripheral neuropathic pain and complex regional pain syndromes. Pain
1997;73:123–39 [review].
35. Hautkappe M, Roizen MF, Toledano A, et al. Review of the
effectiveness of capsaicin for painful cutaneous disorders and neural dysfunction. Clin J
Pain 1998;14:97–106 [review].
36. Fusco BM, Giacovazzo M. Peppers and pain. The promise of capsaicin.
Drugs 1997;53:909–14 [review].
37. Robbins WR, Staats PS, Levine J, et al. Treatment of intractable pain
with topical large-dose capsaicin: preliminary report. Anesth Analg
1998;86:579–83.
38. Zhang WY, Li Wan Po A. The effectiveness of topically applied
capsaicin. A meta-analysis. Eur J Clin Pharmacol 1994;46:517–22 [review].
39. Ellison N, Loprinzi CL, Kugler J, et al. Phase III placebo-controlled
trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients.
J Clin Oncol 1997;15:2974–80.
40. Rains C, Bryson HM. Topical capsaicin. A review of its
pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic
neuropathy and osteoarthritis. Drugs Aging 1995;7:317–28 [review].
41. Lin DZ, Fang YS. Modern Study and Application of Materia
Medica. Hong Kong: China Ocean Press, 1990, 323–5.
42. Hedner T, Everts B. The early clinical history of salicylates in
rheumatology and pain. Clin Rheumatol 1998;17:17–25.
43. Cherng CH, Wong CS, Ho ST. Spinal actions of non-steroidal
anti-inflammatory drugs. Acta Anaesthesiol Sin 1996;34:81–8.
44. Robbers JE, Tyler VE. Tyler’s Herbs of Choice: The
Therapeutic Use of Phytomedicinals. New York: Haworth Press, 1999, 200–4.
45. Santos AR, Filho VC, Yunes RA, et al. Analysis of the mechanisms
underlying the antinociceptive effects of extracts of plants from the genus Phyllanthus.
Gen Pharmacol 1995;26:1499–506.
46. Cechinel Filho V, Santos AR, De Campos RO, et al. Chemical and
pharmacological studies of Phyllanthus caroliniensis in mice. J Pharm Pharmacol
1996;48:1231–6.
47. Miguel OG, Calixto JB, Santos Ar, et al. Chemical and preliminary
analgesic evaluation of geraniin and furosin isolated from Phyllanthus sellowianus, Planta
Med 1996;62:146–9.
48. Syamasundar KV, Singh B, Thakur RS, et al. Antihepatotoxic principles
of Phyllanthus niruri herbs. J Ethnopharmacol 1985;14:41–4.
49. Tapio D, Hymes AC. New Frontiers in TENS. Minnetonka, MN:
LecTec Corporation, 1987, 63–9.
50. Nicholas JJ. Physical modalities in rheumatologic rehabilitation.
Arch Phys Med Rehabil 1994;75:994–9.
51. Gersh, MR. Transcutaneous electrical nerve stimulation (TENS) for
management of pain and sensory pathology. In Electrotherapy in Rehabilitation.
Philadelphia: F.A. Davis Company, 1992.
52. Long DM. Fifteen years of of transutaneous electrical stimulation for
pain control. Stereotact Funct Neurosurg 1991;56:2–19.
53. Carroll D, Tramer M, McQuay H, et al. Randomization is important in
studies with pain outcomes: systemic review of transcutaneous electrical nerve stimulation in
acute postoperative patients. Br J Anaesth 1996;77:798–803.
54. Oliveri AC, Clelland JA, Jackson J, Knowles C. Effects of auricular
transcutaneous electrical nerve stimulation on experimental pain threshold. Phys Ther
1986;66:12–6.
55. Lander J, Fowler-Kerry S. TENS for children’s procedural pain.
Pain 1993;52:209–16.
56. Long DM. Current status of electrical stimulation on the nervous
system for the relief of chronic pain. Surg Neurol 1998;49:142–4.
57. Robin O, Vinard H, Vernet-Maury E, Saumet JL. Influence of sex and
anxiety on pain threshold and tolerance. Funct Neurol 1987;2:173–9.
58. Rybarczyk B, DeMarco G, DeLaCruz M, Lapidos S. Comparing mind-body
wellness interventions for older adults with chronic illness: classroom versus home
instruction. Behav Med 1999;24:181–90.
59. U.S. Department of Health and Human Services. Public Health Service.
Acupuncture. NIH Consensus Statement 1997;15:1–34.
60. Vernon H. Qualitative review of studies of manipulation-induced
hypoalgesia. J Manipulative Physiol Ther 2000;23:134–8.
61. Glover JR, Morris JG, Khosla T. Back pain: a randomized clinical
trial of rotational manipulation of the trunk. Br J Indust Med
1974;31:59–64.
62. Terrett ACJ, Vernon HT. Manipulation and pain tolerance: a controlled
study of the effect of spinal manipulation on paraspinal cutaneous pain tolerance levels.
Am J Phys Med 1984;63:217–25.
63. Vernon HT, Aker P, Burns S, et al. Pressure pain threshold evaluation
of the effect of spinal manipulation in the treatment of chronic neck pain: a pilot study.
J Manipulative Physiol Ther 1990;13:13–6.
64. Vicenzino B, Collins D, Benson H, Wright A. The initial effects of a
cervical spine manipulative physiotherapy treatment on the pain and dysfunction of lateral
epicondylagia. Pain 1996;68:69–74.
65. Cote P, Mior SA. The short-term effect of a spinal manipulation on
pain/pressure threshold in patients with chronic mechanical low back pain. J Manipulative
Physiol Ther 1994;17:36–48.
66. Vernon HT, Dhami MS, Howley, TP, et al. Spinal manipulation and
B-endorphin: a controlled study of the effect of a spinal manipulation on plasma B-endorphin
levels in normal males. J Manipulative Physiol Ther 1986;9:115–23.
67. Christian GF, Stanton GJ, Sissons D, et. al. Immunoreactive ACTH,
B-endorphin and cortisol levels in plasma following spinal manipulative therapy.
Spine 1988;13:141–7.
68. Sanders GE, Reinnert O, Pepe R, et al. Chiropractic adjustive
manipulation on subjects with acute low back pain: visual analogue scores and plasma
b-endorphin levels. J Manipulative Physiol Ther 1990;13:391–5.
69. Lang EV, Benotsch EG, Fick LJ, et al. Adjunctive non-pharmacological
analgesia for invasive medical procedures: a randomised trial. Lancet
2000;355:1486–90.